Atlas FDA

Yeastone Broth, 11ML, 10/BOX YY3462

FDA device recall Z-1806-2026 · posted 2026-04-10 · Open, Classified

Recall details

Recalling firm
Remel, Inc
Reason for recall
Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.
Action taken
Firm began notifying consignees on March 24, 2026 via letters titled "Urgent: Medical Device Recall." Customers were informed that the affected products may report incorrect AST results during quality control. Customers were asked to notify any personnel who need to be aware of the issue. Laboratory professionals are advised to review previously reported susceptibility results generated using affected lots and assess whether retesting is appropriate. Remaining inventory of affected lots must be destroyed; these lots should not be used for any clinical laboratory testing. The firm is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence.
Root cause
Under Investigation by firm
Status
Open, Classified
Product code
NGZ
Quantity affected
2819
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, Singapore.
Date initiated
2026-03-24
Date posted
2026-04-10
Location
Lenexa, KS

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
SENSITITRE YEASTONE SUSCEPTIBILITY PLATES (K090968)Trek Diagnostic Systems, Inc.2009-06-04